Objective: To determine if the Revised Cardiac Risk Index (Lee) is useful for stratification of patients by risk of both perioperative cardiac morbidity and long-term all-cause mortality in the setting of endovascular repair of abdominal aortic aneurysms.
P
ERIOPERATIVE CARDIAC COMPLICATIONS are a major cause for morbidity and mortality in patients with multiple cardiac risk factors undergoing abdominal aortic aneurysm repair. The incidence of perioperative myocardial ischemic injury in patients undergoing vascular surgery may be as high as 18% to 35% in the highest-risk patients. [1] [2] [3] Furthermore, a perioperative myocardial infarction after a noncardiac operation is associated with an increased risk of death. [4] [5] [6] [7] In the past decade, endovascular abdominal aortic aneurysm repair (EAAAR) has evolved as an alternative to the traditional open surgical approach. A number of trials have shown substantial reductions in perioperative mortality and morbidity with endovascular repair of abdominal aortic aneurysm as compared with open surgical repair. [8] [9] [10] [11] Schouten et al 12 showed that, even in patients at high risk, endovascular treatment reduces the incidence of perioperative myocardial complications as compared with open repair. Although the Dutch Randomized Endovascular Aneurysm Management (DREAM) trial and the Endovascular Aneurysm Repair (EVAR)-1 trial showed a perioperative benefit for patients treated endovascularly, both trials failed to show a benefit in overall survival after a median follow-up of 1.8 and 2.9 years, respectively. Importantly, the EVAR-2 trial results indicate that high-risk patients deemed unfit for open surgical repair who undergo endovascular repair have the same rate of cardiovascular-related deaths as patients randomized to no repair of their aneurysm during a median follow-up of 2.4 years. 13 It has been argued that open abdominal aneurysm repair might be considered the ultimate cardiac stress test. If a patient survives the operation, the overall cardiac prognosis might not be that bad. 12 This selection by "survival of the fittest" does not as readily occur in patients who undergo endovascular repair, and adverse cardiac events remain a major source of long-term morbidity and mortality after EAAAR. Although several risk-scoring systems have been derived for patients undergoing open aortic repair, these appear to lack accuracy when applied to EAAAR patients. [14] [15] [16] [17] Only Baas et al 18 were able to show that the Glasgow Aneurysm Score (GAS) is a good predictor of 30-day and 2-year mortality in the patients from the DREAM trial. Aziz et al 19 identified age 70 years or older, history of myocardial infarction (MI) or congestive heart failure (CHF), and lack of use of preoperative ␤-blocker therapy as independent risk factors for perioperative cardiac events in patients undergoing EAAAR. De Virgilio et al 20 were the first to show that preoperative clinical cardiac risk factors are also significant predictors of long-term mortality after endovascular repair of abdominal aortic aneurysms. To the best of the authors' knowledge, this is the first attempt at applying the Revised Cardiac Risk Index (RCRI) to patients undergoing EAAAR for prediction of perioperative major adverse cardiac events (MACEs) as well as long-term all-cause mortality.
METHODS
After obtaining institutional review board approval, a single reviewer (C.R.R.) collected data from the medical records, office charts, and physician quality-assurance databases of a single surgeon's consecutive series of patients admitted to a single academic institution for endovascular aortic aneurysm repair from 1999 to 2006. Patients who had emergent placement of endovascular aortic stents, patients who had non-Food and Drug Administration-approved stents placed, and patients who received Ancure (Endovascular Technologies, Menlo Park, CA) stents were excluded from the study. The latter group of patients was excluded because the Ancure stent has since been removed from the market. The collected data included all preoperative demographics and risk factors as outlined by the American Heart Association/American College of Cardiology guidelines 21 as well as the Lee Revised Cardiac Risk Index score, the Glasgow Aneurysm Risk score, and documentation on perioperative cardiovascular medication use. Longterm mortality was assessed searching public records by using Social Security numbers. The primary endpoints were in-hospital MACEs, as defined by cardiac death (medical records, electrocardiogram [ECG] findings, and elevated cardiac enzymes consistent with a fatal myocardial infarction), non-fatal myocardial infarction (ECG findings consistent with infarction and/or elevated cardiac enzymes), unstable angina (new or increased chest pain with ECG changes consistent with ischemia), new onset or worsening of CHF (clinical examination or chest radiograph consistent with heart failure and/or elevated brain natriuretic peptide), or coronary revascularization at any time during hospitalization, as documented in the medical records. A secondary endpoint was all-cause mortality during the follow-up period. All statistical analyses were performed by using JMP version 7.0.2 software (SAS Institute, Cary, NC). Continuous data are presented as mean values, whereas dichotomous data are presented as percentages. Univariate analyses of likelihood ratios and odds ratios for perioperative MACEs, death at 1 year, death at 2 years, and death by end of follow-up were calculated by using chi-square tests or Fisher exact tests, as appropriate. Receiver-operating characteristic (ROC) curves were generated for GAS and RCRI for perioperative MACE and death at 1 year, respectively. For predictive ability, an area under the curve (AUC) of 0.5 is recognized as no better than chance, 0.6 to 0.7 as poor, 0.7 to 0.8 as fair, 0.8 to 0.9 as good, and 0.9 to 1.0 as excellent. 22 A modified Lee index for prediction of long-term all-cause mortality was created by adding 1 to the preoperative score if a perioperative MACE had occurred and ROC curves were generated for this modified Lee index as well.
RESULTS
After excluding patients as described under the Methods section, a total of 225 subjects were reviewed (Table 1) ; 85.8% were males, more than 90% were white, and the prevalence of significant medical comorbidities, including hypertension (85.3%), history of tobacco use (82.2% either past or current), and CAD (74.2%), were considerably higher in comparison to other studies. 8, [10] [11] [12] [13] 23 Ninety-seven patients had 1, 78 patients had 2, and 50 patients had 3 or more RCRI factors. The average age of the participants was 73.8 years (standard deviation ϭ 9); 52.4% were on ␤-blockers preoperatively, 50.5% were statin users; 33.6% experienced perioperative statin discontinuation and only 8.4% ␤-blocker withdrawal, defined as more than 48 hours before statin/␤-blocker administration was resumed postoperatively. Patient follow-up was complete up to October 2006, and the median length of follow-up was 759 days.
With respect to the primary endpoint, there were no inhospital cardiac deaths; 10 nonfatal MIs (4.4%), 9 of which were non-ST elevation MIs; and only 1 ST-elevation myocardial infarction (STEMI). Seven patients sustained a new onset or worsening of CHF during hospitalization (3.1%), and 4 patients had unstable angina (1.8%). All patients with unstable angina also had a myocardial infarction, and 3 patients with AMI (non-STEMI) also had CHF. In total, 14 patients (6.2%) suffered at least 1 MACE in the perioperative period. There were no coronary revascularization procedures. The number of patients reaching the primary endpoint based on the number of RCRI factors was distributed as follows: among patients with 1 Table 2 ). The ROC curve analysis for RCRI score revealed an AUC of 0.73 for predicting postoperative cardiac events. The AUCs for the prediction of postoperative cardiac events by age and GAS were 0.60 and 0.67, respectively. Of note, 3 patients (1.3%) died in the perioperative period, 1 patient suffered rupture and death in the operating room before the beginning of the operation and 2 patients died in the intensive care unit from primary pulmonary causes (Figs 1 and 2) .
With respect to the secondary endpoint, 52 patients (23%) died during follow-up with an average length of survival of 672 days (standard deviation ϭ 571). Of the patients who suffered a perioperative MACE, 5 died within 1 year; 6 within 2 years; and, by the end of follow-up, 10 (71.4%) had died. Of the patients without a MACE in the perioperative period, 13 died within 1 year; 25 within 2 years; and, by the end of follow-up, 42 (19.9%) had died (Fig 3) . The incidence of secondary outcomes based on RCRI class was as follows: among patients with 1 RCRI factor 17 (17.5%), 2 RCRI factors 17 (21.8%), and 3 or more RCRI factors 18 (36%). Univariate analysis showed that an RCRI Ն3 (LR ϭ 14, p ϭ 0.0002), echocardiographic evidence of MI (LR ϭ 12.4, p ϭ 0.0005), history of CAD (LR ϭ 5.5, p ϭ 0.048), history of CHF (LR ϭ 8, p ϭ 0.005), exercise tolerance of only 1 block (LR ϭ 5.7, p ϭ 0.015), and perioperative MACE (LR ϭ 9.6, p ϭ 0.002) were predictors of 1-year mortality ( Table 3 ). The ROC curve analysis for the RCRI score revealed an AUC of 0.72 for predicting death at 1 year, and the calculated AUC for the modified RCRI score in which the authors simply added 1 for those patients who sustained 1 or more postoperative cardiac events was 0.75. For death at 2 years, only echocardiographic evidence of MI (LR ϭ 11.3, p ϭ 0.0008), exercise tolerance of only 1 block (LR ϭ 8, p ϭ 0.007), history of CAD (LR ϭ 5.8, p ϭ 0.027), and perioperative MACE (LR ϭ 7.7, p ϭ 0.006) remained highly significant predictors (Table 4) . A history of CAD (LR ϭ 10.7, p ϭ 0.002), echocardiographic evidence of MI (LR ϭ 8.5, p ϭ 0.006), exercise tolerance of only 1 block (LR ϭ 8.4, p ϭ 0.005), RCRI Ն3 (LR ϭ 5.6, p ϭ 0.022), and perioperative cardiac events (LR ϭ 15.9, p Ͻ 0.0001) were significantly associated with long-term all-cause mortality (Table 5) . What is remarkable is that MACEs remained highly significant in predicting mortality within the RCRI Ն3 subgroup (LR ϭ 6.1, p ϭ 0.019), Abbreviations: CI, confidence interval; hx, history; CCVS, Canadian Cardiovascular Society; CABG, coronary artery bypass graft; ACC/ AHA, American College of Cardiology/American Heart Association; COPD, chronic obstructive pulmonary disease.
*Not computable because the number of patients with a history of CAD/CCVS class IV who did not have an event equals 0. indicating that MACEs allow further risk stratification even among the highest-risk patients (Fig 4) .
DISCUSSION
With progressive reduction of in-hospital mortality, the assessment of patient longevity after abdominal aortic aneurysm repair is an important factor in clinical decision-making with regard to the choice of procedure as well as for the optimization of medical therapy. Preoperative risk assessment of patients undergoing major noncardiac surgery has been designed to identify patients at increased risk for perioperative mortality and morbidity. However, there is a strong relationship between perioperative cardiac and noncardiac complications and subsequent mortality; almost half of the patients who experience cardiac morbidity develop other types of noncardiac complications and mortality. 24 Clinical cardiac risk factors have been found to be useful predictors of perioperative cardiac events after numerous types of vascular procedures. 19, 25, 26 The Lee index, which was derived from a dataset of 4,315 patients undergoing noncardiac surgery on the basis of the original Goldman index, is now considered by many clinicians and researchers to be the most relevant index to predict cardiac risk. 27 The fact that the ACC/AHA Committee incorporated the RCRI in the 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery further emphasizes its significance. 21 Boersma et al 28 adapted the Lee index for prediction of cardiovascular mortality in 108,593 patients who underwent noncardiac surgery in the Erasmus Medical Center from 1991 to 2000. By adding age and more detailed information regarding the type of surgery, they were able to increase the AUC for the prediction of cardiovascular mortality using the Lee index from 0.63 to 0.85.
In the present series of 225 patients undergoing EAAAR, the authors found the following factors associated with decreased long-term survival: echocardiographic evidence of MI, RCRI Ն3, exercise tolerance of only 1 block, and postoperative cardiac events.
Endoluminal graft repair is a less invasive and less hemodynamically stressful technique than standard open repair and is thus intuitively appealing in patients at high risk. The less invasive nature of endoluminal graft repair would suggest that standard methods for cardiac risk stratification for open vascular surgery might not be applicable. Indeed, a number of risk indices originally developed for open repair were evaluated for EAAAR and generally found to be poor predictors. [14] [15] [16] [17] Bohm et al 14 reported that the GAS, the Vascular Physiology and Operative Severity Score for the enUmeration of Mortality and Morbidity, the modified Customized Probability Index, and the Customized Probability Index showed AUCs of 0.68, 0.66, 0.63, and 0.65 for prediction of 30-day mortality. Sajid et al 15 found that both the GAS and the Hardman Index overestimate mortality and morbidity after EAAAR in their small sample of 71 patients. After validating the GAS, the Modified Leiden Score, and the Modified Comorbidity Severity Score to their open repair dataset, Faizer et al 16 calculated C-statistics for the prediction of perioperative mortality in the EAAAR group. With AUCs of 0.47 (GAS), 0.70 (Modified Leiden Score), and 0.69 (Modified Comorbidity Severity Score), these stratification systems performed rather poorly. Biancari et al 17 reported Abbreviations: CI, confidence interval; hx, history; CCVS, Canadian Cardiovascular Society; CABG, coronary artery bypass graft; BB, ␤-blocker; ACC/AHA, American College of Cardiology/American Heart Association; COPD, chronic obstructive pulmonary disease. an AUC of 0.70 for the prediction of postoperative death by GAS in patients from the EUROSTAR Registry. Baas et al 18 successfully applied the GAS as a tool for prediction of 30-day and 2-year mortality in the patients from the DREAM trial. Unfortunately, it proved most valuable in identifying low-risk patients but was not very useful for the identification of highrisk patients.
In the present study, the authors found a highly significant association between a Lee index Ն3 and postoperative cardiac events (p ϭ 0.004) as well as 1-year mortality (p ϭ 0.0002) and long-term mortality (p ϭ 0.02). These results indicate that the Lee index, even if its overall discriminatory ability is fair at best, is a useful tool for the identification of high-risk patients from both a short-and long-term perspective. Although the Lee index was developed for the prediction of prospectively detected major cardiac complications and not for the prediction of (cardiovascular) death, it may be easier to predict the incidence of death than to predict a broader range of clinical outcomes. 29 The second major finding of this study was that a postoperative MACE was a highly significant predictor of mortality at 1 year (LR ϭ 9.6, p ϭ 0.002) as well as at 2 years (LR ϭ 7.7, p ϭ 0.006) and by the end of follow-up (LR ϭ 15.9, p Ͻ 0.0001). Postoperative cardiac events proved that they had value for risk stratification even among the highest-risk (RCRI Ն 3) group of patients. In contrast to what was reported by de Virgilio et al, 20 the present data show that long-term survival is significantly impaired even after minor perioperative infarction, in line with what occurs found after acute coronary syndromes in nonsurgical patients and what was reported for the setting of major vascular surgery by Landesberg et al 30 and Bursi et al. 31 The fact that exercise tolerance of no more than 1 block was Abbreviations: CI, confidence interval; hx, history; CCVS, Canadian Cardiovascular Society; CABG, coronary artery bypass graft; BB, ␤-blocker; ACC/AHA, American College of Cardiology/American Heart Association; COPD, chronic obstructive pulmonary disease.
*Not computable because the number of patients with CCVS class IV who survived equals 0.
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highly associated with long-term mortality in the present study reinforces the emphasis of functional capacity as a tool for risk stratification, as advocated in the ACC/AHA Guidelines. Importantly, using a lower cutoff of 1 block was able to discriminate risk even in a population with limited exercise capacity. One of the major limitations of the present study was that it was a retrospective review, and the authors could only determine mortality by death certificates. For this reason, the authors analyzed all-cause mortality rather than attempting to determine long-term cardiac mortality. Although the availability of such data would be highly desirable, numerous previous studies showed that the majority of deaths in vascular surgery patients are cardiac in nature and that nearly half of the other noncardiac causes of death are cardiovascular. [32] [33] [34] [35] The authors were also limited in the number of factors that could be analyzed because of sample size. The authors' institution actively participated in Food and Drug Administration-approved phase I and pivotal stent graft trials in the late 1990s and early 2000s, and, therefore, more than half of the patients potentially meeting the inclusion criteria were being enrolled in studies that excluded them from the present study.
In conclusion, the present results confirm that long-term mortality remains high after EAAAR. The Lee index may be useful for risk stratification in the setting of endoluminal graft repair. Once a patient develops a perioperative myocardial ischemic injury, further evaluation for CAD may be warranted. Whether more aggressive treatment of patients with postoperative cardiac events can improve survival needs to be further investigated.
